Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.355 USD | -1.05% | -10.11% | +1.51% |
May. 09 | Transcript : Mersana Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q1 Revenue $9.2M, vs. Street Est of $8.5M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.51% | 291M | |
+9.84% | 118B | |
+10.24% | 106B | |
-11.88% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.75% | 15.97B | |
+6.11% | 14.03B | |
+15.14% | 11.67B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Wedbush Upgrades Mersana Therapeutics to Outperform From Neutral, Notes Increased Confidence in Program; Adjusts PT to $7 From $2